Recruiting Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease NCT07051863 Conditions Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more Locations Fondazione Epatocentro Ticino — Lugano, Canton Ticino, Switzerland View Trial Details
Active, Not Recruiting A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT06161571 Conditions Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more Locations Akero Clinical Study Site — Birmingham, Alabama, United States Akero Clinical Study Site — Chandler, Arizona, United States Akero Clinical Study Site — Flagstaff, Arizona, United States Akero Clinical Study Site — Peoria, Arizona, United States View all 211 locations View more locations Show fewer locations Loading locations... View Trial Details
